Crispr Therapeutics shares owned by C.M. Bidwell & Associates
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by C.M. Bidwell & Associates
from 13F filings
Historical chart of C.M. Bidwell & Associates investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by C.M. Bidwell & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by C.M. Bidwell & Associates
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-09-30 | $142k | 3.1k | 45.39 |
2023-06-30 | $136k | 2.4k | 56.14 |
2023-03-31 | $77k | 1.7k | 45.23 |
2022-12-31 | $2.3k | 56 | 40.64 |
2022-09-30 | $1.0k | 18 | 55.56 |
2022-06-30 | $3.0k | 53 | 56.60 |
2022-03-31 | $3.0k | 53 | 56.60 |
2021-12-31 | $2.0k | 25 | 80.00 |